Cost of Care for Juvenile Idiopathic Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01469897|
Recruitment Status : Completed
First Posted : November 10, 2011
Last Update Posted : January 17, 2018
|Condition or disease|
|Juvenile Idiopathic Arthritis|
SPECIFIC AIMS AND OBJECTIVES
The specific aims of this registry protocol are:
- To create and maintain a secure online database of patients with JIA
- To collect data elements related to cost of care in patients with JIA
- Compare standard outcome and disease activity measures to health care expenditures in JIA
- To determine methods by which to reduce costs while improving outcomes and quality of care
The study plans to enroll 300 or more subjects from 3 medical centers in the US over a 24 month period. Subjects in the study are patients with Juvenile Idiopathic Arthritis.
Enrollment into the protocol will include key demographic and clinical data including, medication exposures, disease severity, and function including disease-specific data elements; and estimates of health care service utilization and health care expenditures. Data will be collected once per subject within the context of a standard of care visit.
|Study Type :||Observational|
|Actual Enrollment :||165 participants|
|Official Title:||Cost of Care for Juvenile Idiopathic Arthritis|
|Study Start Date :||January 2012|
|Primary Completion Date :||December 2014|
|Study Completion Date :||March 2017|
- Direct and indirect costs [ Time Frame: 6 months prior to enrollment ]Patient's history will be reviewed for the prior 6 months to enrollment for expenses incurred related to JIA and it's treatment. This will be done through chart review and questionnaires completed by the patient/parent.
- Health related quality of life questionnaires [ Time Frame: Day 1 ]Self reported questionnaires will be completed by parent.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01469897
|United States, Nebraska|
|Children's Hospital & Medical Center|
|Omaha, Nebraska, United States, 68114|
|United States, Ohio|
|The Cleveland Clinic|
|Cleveland, Ohio, United States, 44195|
|United States, Texas|
|Dell Childrens Medical Center of Central Texas|
|Austin, Texas, United States, 78723|
|Principal Investigator:||Andrew Zeft, MD||Cleveland Clinic Children's Hospital|